PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för leflunomide. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

68 hits

Bibliografisk träff 2005-01-01

Effectiveness and safety profile of leflunomide in rheumatoid arthritis: actual practice compared with clinical trials.

Martin K, Bentaberry F, Dumoulin C, Dehais J, Haramburu F, Bégaud B, Schaeverbeke T.

Clin Exp Rheumatol · comparative study; journal article

Bibliografisk träff 2004-12-01

Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infection.

Avery RK, Bolwell BJ, Yen-Lieberman B, Lurain N, Waldman WJ, Longworth DL, Taege AJ, Mossad SB, Kohn D, Long JR, Curtis J, Kalaycio M, Pohlman B, Williams JW.

Bone Marrow Transplant · journal article; case reports · DOI 10.1038/sj.bmt.1704694

Bibliografisk träff 2004-11-10

Regulation of ultraviolet B-induced phosphorylation of histone H3 at serine 10 by Fyn kinase.

He Z, Cho YY, Ma WY, Choi HS, Bode AM, Dong Z.

J Biol Chem · research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; journal article · DOI 10.1074/jbc.m402053200

Bibliografisk träff 2004-11-01

CPEC induces erythroid differentiation of human myeloid leukemia K562 cells through CTP depletion and p38 MAP kinase.

Huang M, Wang Y, Collins M, Graves LM.

Leukemia · research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; journal article · DOI 10.1038/sj.leu.2403490

Bibliografisk träff 2004-06-01

Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trial.

Kaltwasser JP, Nash P, Gladman D, Rosen CF, Behrens F, Jones P, Wollenhaupt J, Falk FG, Mease P, Treatment of Psoriatic Arthritis Study Group.

Arthritis Rheum · clinical trial; multicenter study; randomized controlled trial; journal article · DOI 10.1002/art.20253

Bibliografisk träff 2004-06-01

Leflunomide as a novel treatment option in severe atopic dermatitis.

Schmitt J, Wozel G, Pfeiffer C.

Br J Dermatol · journal article; case reports · DOI 10.1111/j.0007-0963.2003.05846.x

Bibliografisk träff 2004-03-01

Additive effects of leflunomide and tacrolimus in prevention of islet xenograft rejection.

Zhang L, Qi Z, Wu D, Shan S, Ekberg H.

Scand J Immunol · journal article · DOI 10.1111/j.0300-9475.2004.01401.x

Bibliografisk träff 2004-03-01

Tailoring immunosuppressive therapy in interstitial lung diseases.

Agostini C.

Sarcoidosis Vasc Diffuse Lung Dis · review; journal article

Bibliografisk träff 2004-03-01

Leflunomide for chronic sarcoidosis.

Baughman RP, Lower EE.

Sarcoidosis Vasc Diffuse Lung Dis · clinical trial; journal article · DOI 10.1007/s11083-004-5178-y

Bibliografisk träff 2003-06-01

Simultaneous determination of leflunomide and its active metabolite, A77 1726, in human plasma by high-performance liquid chromatography.

Schmidt A, Schwind B, Gillich M, Brune K, Hinz B.

Biomed Chromatogr · journal article · DOI 10.1002/bmc.244

Bibliografisk träff 2002-10-01

The active metabolite of leflunomide, an immunosuppressive agent, reduces mechanical sensitivity in a rat mononeuropathy model.

Sweitzer SM, DeLeo JA.

J Pain · journal article · DOI 10.1054/jpai.2002.125181

Bibliografisk träff 2002-04-01

[Leflunomide in systemic lupus erythematosus].

Kessel A, Toubi E.

Harefuah · editorial; case reports

Bibliografisk träff 2002-02-01

Experiences with leflunomide in solid organ transplantation.

Williams JW, Mital D, Chong A, Kottayil A, Millis M, Longstreth J, Huang W, Brady L, Jensik S.

Transplantation · journal article · DOI 10.1097/00007890-200202150-00008

Bibliografisk träff 2002-02-01

[Leflunomide in the treatment of rheumatoid arthritis].

Wendling D.

Ann Med Interne (Paris) · review; journal article

Bibliografisk träff 2002-01-01

Clinical pharmacokinetics of leflunomide.

Rozman B.

Clin Pharmacokinet · journal article · DOI 10.2165/00003088-200241060-00003

Bibliografisk träff 2001-11-01

Inhibition of angiogenesis-related endothelial activity by the experimental immunosuppressive agent leflunomide.

Waldman WJ, Bickerstaff A, Gordillo G, Orosz K, Knight DA, Orosz CG.

Transplantation · research support, u.s. gov't, p.h.s.; journal article · DOI 10.1097/00007890-200111150-00018

Bibliografisk träff 2001-11-01

[Leflunomide--a new disease modifying anti-rheumatic agent].

Rødevand E, Kvien TK, Johnsen V.

Tidsskr Nor Laegeforen · review; journal article

Bibliografisk träff 2001-09-01

Suppression of experimental autoimmune neuritis by leflunomide.

Korn T, Toyka K, Hartung HP, Jung S.

Brain · journal article · DOI 10.1093/brain/124.9.1791

Bibliografisk träff 2001-08-01

The Saccharomyces cerevisiae MLF6/YPL244C gene, which encodes a possible yeast homologue of mammalian UDP-galactose transporter, confers resistance to the immunosuppressive drug, leflunomide.

Fujimura H.

Curr Microbiol · journal article · DOI 10.1007/s002840010267

Bibliografisk träff 2001-05-01

Leflunomide and methotrexate.

Laan RF, van Riel PL, van de Putte LB.

Curr Opin Rheumatol · review; journal article · DOI 10.1097/00002281-200105000-00002

Bibliografisk träff 2001-04-01

Leflunomide: new antirheumatic drug. Effect on pregnancy outcomes.

Kozer E, Moretti ME, Koren G.

Can Fam Physician · research support, non-u.s. gov't; research-article; journal article; case reports

Bibliografisk träff 2001-04-01

Leflunomide and rheumatoid arthritis: new preparation. Neither the safest nor the most effective slow-acting antirheumatic drug.

Författaruppgift saknas

Prescrire Int · comparative study; journal article

Bibliografisk träff 2001-02-01

[Leflunomide--the first specific disease-modifying drug against rheumatoid arthritis].

Ringertz B, Petersson I.

Lakartidningen · journal article

Bibliografisk träff 2000-11-01

Leflunomide: mode of action in the treatment of rheumatoid arthritis.

Breedveld FC, Dayer JM.

Ann Rheum Dis · review-article; review; journal article · DOI 10.1136/ard.59.11.841

Bibliografisk träff 2000-11-01

Leflunomide suppresses TNF-induced cellular responses: effects on NF-kappa B, activator protein-1, c-Jun N-terminal protein kinase, and apoptosis.

Manna SK, Mukhopadhyay A, Aggarwal BB.

J Immunol · research support, non-u.s. gov't; journal article · DOI 10.4049/jimmunol.165.10.5962

Bibliografisk träff 2000-09-01

[Leflunomide for active rheumatoid arthritis].

Andresen PN, Hansen G, Hørslev-Petersen K.

Ugeskr Laeger · review; journal article

Bibliografisk träff 2000-06-01

The potential of newer immunomodulating drugs in the treatment of uveitis: a review.

Salzmann J, Lightman S.

BioDrugs · journal article · DOI 10.2165/00063030-200013060-00003

Bibliografisk träff 1999-11-01

Leflunomide, a novel immunomodulator for the treatment of active rheumatoid arthritis.

Goldenberg MM.

Clin Ther · review; journal article · DOI 10.1016/s0149-2918(00)86732-6

Bibliografisk träff 1999-09-01

Novel mechanism of inhibition of cytomegalovirus by the experimental immunosuppressive agent leflunomide.

Waldman WJ, Knight DA, Lurain NS, Miller DM, Sedmak DD, Williams JW, Chong AS.

Transplantation · research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; journal article · DOI 10.1097/00007890-199909270-00014

Bibliografisk träff 1999-01-01

Inhibition of cytomegalovirus in vitro and in vivo by the experimental immunosuppressive agent leflunomide.

Waldman WJ, Knight DA, Blinder L, Shen J, Lurain NS, Miller DM, Sedmak DD, Williams JW, Chong AS.

Intervirology · research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; journal article · DOI 10.1159/000053979